ATE360392T1 - In vivo multiphoton diagnostische detektion und bilddarstellung einer neurodegenerativen erkrankung - Google Patents

In vivo multiphoton diagnostische detektion und bilddarstellung einer neurodegenerativen erkrankung

Info

Publication number
ATE360392T1
ATE360392T1 AT01999158T AT01999158T ATE360392T1 AT E360392 T1 ATE360392 T1 AT E360392T1 AT 01999158 T AT01999158 T AT 01999158T AT 01999158 T AT01999158 T AT 01999158T AT E360392 T1 ATE360392 T1 AT E360392T1
Authority
AT
Austria
Prior art keywords
brain tissue
fluorescence
mammal
neurodegenerative disease
imaging
Prior art date
Application number
AT01999158T
Other languages
English (en)
Inventor
Bradley T Hyman
Richard Christie
Brian Bacskai
Watt W Webb
Warren R Zipfel
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Application granted granted Critical
Publication of ATE360392T1 publication Critical patent/ATE360392T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • G01N21/6458—Fluorescence microscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/004—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A61B5/0042—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1075—Measuring physical dimensions, e.g. size of the entire body or parts thereof for measuring dimensions by non-invasive methods, e.g. for determining thickness of tissue layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
    • A61B5/4064—Evaluating the brain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Developmental Disabilities (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01999158T 2000-11-02 2001-10-31 In vivo multiphoton diagnostische detektion und bilddarstellung einer neurodegenerativen erkrankung ATE360392T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24530600P 2000-11-02 2000-11-02

Publications (1)

Publication Number Publication Date
ATE360392T1 true ATE360392T1 (de) 2007-05-15

Family

ID=22926133

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01999158T ATE360392T1 (de) 2000-11-02 2001-10-31 In vivo multiphoton diagnostische detektion und bilddarstellung einer neurodegenerativen erkrankung

Country Status (8)

Country Link
US (1) US7668586B2 (de)
EP (1) EP1347731B1 (de)
JP (1) JP2004518488A (de)
AT (1) ATE360392T1 (de)
AU (1) AU2002251682A1 (de)
CA (1) CA2427014A1 (de)
DE (1) DE60128138T2 (de)
WO (1) WO2002064084A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US6787523B1 (en) * 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
US7790856B2 (en) * 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
US7700751B2 (en) * 2000-12-06 2010-04-20 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize β-amyloid peptide
US7534255B1 (en) 2003-01-24 2009-05-19 Photothera, Inc Low level light therapy for enhancement of neurologic function
US7303578B2 (en) 2001-11-01 2007-12-04 Photothera, Inc. Device and method for providing phototherapy to the brain
MY139983A (en) * 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
AU2002951841A0 (en) 2002-09-30 2002-10-24 Swinburne University Of Technology Apparatus
MXPA05008156A (es) * 2003-02-01 2005-09-30 Neuralab Ltd Inmunizacion activa para generar anticuerpos para beta-a soluble.
US7706863B2 (en) * 2004-01-21 2010-04-27 University Of Washington Methods for assessing a physiological state of a mammalian retina
US20050259249A1 (en) * 2004-01-27 2005-11-24 Dombeck Daniel A Nonlinear optical detection of fast cellular electrical activity
US8184300B2 (en) * 2004-12-13 2012-05-22 Alexander Mazurenko Method and apparatus for reducing probe wavelength in laser excited surface acoustic wave spectroscopy
ES2434732T3 (es) * 2004-12-15 2013-12-17 Janssen Alzheimer Immunotherapy Anticuerpos para beta-amiloide humanizados para su uso en mejorar la cognición
US20060293644A1 (en) * 2005-06-21 2006-12-28 Donald Umstadter System and methods for laser-generated ionizing radiation
US7801589B2 (en) 2005-12-22 2010-09-21 Olympus Corporation In-vivo examination method and in-vivo examination apparatus
US8012936B2 (en) 2006-03-29 2011-09-06 New York University Tau fragments for immunotherapy
US8784810B2 (en) * 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
DE102006050886B4 (de) * 2006-10-27 2016-12-22 Siemens Healthcare Gmbh Medizinisches Instrument und Einrichtung zur Erzeugung von Gewebeschnittbildern
US20120059254A1 (en) * 2007-03-14 2012-03-08 Wang Lifan Apparatus and method for phase-space reduction for imaging of fluorescing, scattering and/or absorbing structures
US20080292625A1 (en) * 2007-04-18 2008-11-27 Sally Schroeter Prevention and treatment of cerebral amyloid angiopathy
US8003097B2 (en) * 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
SI2182983T1 (sl) * 2007-07-27 2014-09-30 Janssen Alzheimer Immunotherapy Zdravljenje amiloidogenih bolezni s humaniziranimi protitelesi proti abeta
JO3076B1 (ar) * 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
EP2222372A2 (de) * 2007-12-06 2010-09-01 Technion Research & Development Foundation Ltd. Verfahren und system zur optischen stimulierung von neuronen
US20090185980A1 (en) * 2008-01-23 2009-07-23 National Taiwan University In vivo drug screening system
US20120035444A1 (en) * 2008-01-23 2012-02-09 National Taiwan University Intravital sample device for in vivo drug screening
US8954133B1 (en) 2008-08-08 2015-02-10 The United States Of America As Represented By The Department Of Veterans Affairs Spectroscopic detection of brain damage
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
EP2440234A4 (de) 2009-06-10 2013-11-06 Univ New York Immunologische anzielung pathologischer tau-proteine
WO2011114479A1 (ja) * 2010-03-18 2011-09-22 株式会社島津製作所 ホルダ及びそれを用いた光計測装置
US8873827B2 (en) 2012-06-29 2014-10-28 General Electric Company Determination of spatial proximity between features of interest in biological tissue
JP6133053B2 (ja) * 2012-12-21 2017-05-24 浜松ホトニクス株式会社 アミロイドの凝集体の定量方法及びその定量装置
JP6913018B2 (ja) 2014-07-08 2021-08-04 ニューヨーク・ユニバーシティ タウイメージングリガンド、ならびにタウ異常症の診断および治療におけるそれらの使用
US10018817B2 (en) 2015-03-04 2018-07-10 Aramco Services Company Adaptive optics for imaging through highly scattering media in oil reservoir applications
WO2017027685A2 (en) 2015-08-13 2017-02-16 New York University Antibody-based molecules specific for the truncated asp421 epitope of tau and their uses in the diagnosis and treatment of tauopathy
US10394008B2 (en) 2016-10-19 2019-08-27 Cornell University Hyperspectral multiphoton microscope for biomedical applications
WO2019173813A1 (en) * 2018-03-09 2019-09-12 Icahn School Of Medicine At Mount Sinai Multiphoton microscopy assessment of neurologic tissue
CN110313892A (zh) * 2018-03-28 2019-10-11 上海交通大学 基于体表自发荧光判断帕金森病发生的方法及其应用
CN112509020B (zh) * 2020-12-07 2021-09-28 昆山戎影医疗科技有限公司 血管外部影像与腔内影像的配准方法、装置及计算设备
CN113008850B (zh) * 2021-02-07 2022-02-25 首都医科大学宣武医院 诊断阿尔茨海默病的用途及诊断阿尔茨海默病的装置
CN113804166B (zh) * 2021-11-19 2022-02-08 西南交通大学 一种基于无人机视觉的落石运动参数数字化还原方法

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4592361A (en) * 1982-06-28 1986-06-03 The Johns Hopkins University Electro-optical device and method for monitoring instantaneous singlet oxygen concentration produced during photoradiation using pulsed excitation and time domain signal processing
US4576173A (en) * 1982-06-28 1986-03-18 The Johns Hopkins University Electro-optical device and method for monitoring instanteous singlet oxygen concentration produced during photoradiation using a CW excitation source
JPS61159936A (ja) 1985-07-02 1986-07-19 熊谷　博彰 生物組織の分光画像撮影装置
US4895156A (en) * 1986-07-02 1990-01-23 Schulze John E Sensor system using fluorometric decay measurements
ATE133545T1 (de) 1988-12-21 1996-02-15 Massachusetts Inst Technology Verfahren für laserinduzierte fluoreszenz von gewebe
US5119815A (en) * 1988-12-21 1992-06-09 Nim, Incorporated Apparatus for determining the concentration of a tissue pigment of known absorbance, in vivo, using the decay characteristics of scintered electromagnetic radiation
US5386827A (en) 1993-03-30 1995-02-07 Nim Incorporated Quantitative and qualitative in vivo tissue examination using time resolved spectroscopy
SE8900612D0 (sv) * 1989-02-22 1989-02-22 Jonas Johansson Vaevnadskarakterisering utnyttjande ett blodfritt fluorescenskriterium
US5421337A (en) * 1989-04-14 1995-06-06 Massachusetts Institute Of Technology Spectral diagnosis of diseased tissue
US5034613A (en) * 1989-11-14 1991-07-23 Cornell Research Foundation, Inc. Two-photon laser microscopy
US5127405A (en) * 1990-02-16 1992-07-07 The Boc Group, Inc. Biomedical fiber optic probe with frequency domain signal processing
US5062428A (en) * 1990-06-04 1991-11-05 Nim Incorporated Method and device for in vivo diagnosis detecting IR emission by body organ
US5197470A (en) * 1990-07-16 1993-03-30 Eastman Kodak Company Near infrared diagnostic method and instrument
US5438989A (en) 1990-08-10 1995-08-08 Hochman; Darryl Solid tumor, cortical function, and nerve tissue imaging methods and device
CA2042075C (en) 1991-05-08 2001-01-23 Branko Palcic Endoscopic imaging system
US5323775A (en) * 1991-09-13 1994-06-28 Allergan, Inc. Diagnostic method for determining precorneal retention time of ophthalmic formulations
US5353790A (en) * 1992-01-17 1994-10-11 Board Of Regents, The University Of Texas System Method and apparatus for optical measurement of bilirubin in tissue
US5736410A (en) * 1992-09-14 1998-04-07 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US5311013A (en) * 1992-10-15 1994-05-10 Abbott Laboratories Optical fiber distribution system for an optical fiber sensor in a luminescent sensor system
US5333044A (en) * 1992-11-24 1994-07-26 The United States Of America As Represented By The Department Of Energy Fluorescent image tracking velocimeter
US5341805A (en) * 1993-04-06 1994-08-30 Cedars-Sinai Medical Center Glucose fluorescence monitor and method
US5590660A (en) * 1994-03-28 1997-01-07 Xillix Technologies Corp. Apparatus and method for imaging diseased tissue using integrated autofluorescence
US5469653A (en) 1994-04-28 1995-11-28 Roehrick; Harry V. Apparatus and method for pest control
US6168776B1 (en) * 1994-07-19 2001-01-02 University Of Pittsburgh Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US5579773A (en) 1994-09-30 1996-12-03 Martin Marietta Energy Systems, Inc. Laser-induced differential normalized fluorescence method for cancer diagnosis
US5697373A (en) * 1995-03-14 1997-12-16 Board Of Regents, The University Of Texas System Optical method and apparatus for the diagnosis of cervical precancers using raman and fluorescence spectroscopies
US5699795A (en) * 1995-03-31 1997-12-23 Board Of Regents, The University Of Texas System Optical probe for the detection of cervical neoplasia using fluorescence spectroscopy and apparatus incorporating same
US5628310A (en) * 1995-05-19 1997-05-13 Joseph R. Lakowicz Method and apparatus to perform trans-cutaneous analyte monitoring
AU700560B2 (en) 1995-09-19 1999-01-07 Cornell Research Foundation Inc. Multi-photon laser microscopy
DE59606558D1 (de) * 1995-09-26 2001-04-12 Storz Karl Gmbh & Co Kg Vorrichtung zur photodynamischen diagnose
US5720894A (en) * 1996-01-11 1998-02-24 The Regents Of The University Of California Ultrashort pulse high repetition rate laser system for biological tissue processing
JP3796635B2 (ja) 1996-03-06 2006-07-12 富士写真フイルム株式会社 蛍光検出装置
DE19622359B4 (de) 1996-06-04 2007-11-22 Carl Zeiss Jena Gmbh Vorrichtung zur Einkopplung der Strahlung von Kurzpulslasern in einem mikroskopischen Strahlengang
DE19649971A1 (de) * 1996-11-19 1998-05-28 Diagnostikforschung Inst Optische Diagnostika zur Diagnostik neurodegenerativer Krankheiten mittels Nahinfrarot-Strahlung (NIR-Strahlung)
WO1998040007A1 (en) 1997-03-13 1998-09-17 Biomax Technologies, Inc. Methods and apparatus for detecting the rejection of transplanted tissue
US6280386B1 (en) * 1997-06-16 2001-08-28 The Research Foundation Of The City University Of New York Apparatus for enhancing the visibility of a luminous object inside tissue and methods for same
US5986271A (en) 1997-07-03 1999-11-16 Lazarev; Victor Fluorescence imaging system
US6238348B1 (en) 1997-07-22 2001-05-29 Scimed Life Systems, Inc. Miniature spectrometer system and method
US6787523B1 (en) * 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
GB9813062D0 (en) 1998-06-18 1998-08-19 Univ Wales Medicine An anthraquinone and its derivatives
US6472541B2 (en) 1998-11-20 2002-10-29 The Regents Of The University Of California Protecting groups with increased photosensitivities
WO2001008552A1 (en) * 1999-08-03 2001-02-08 Biophysica, Llc Spectroscopic systems and methods for detecting tissue properties
US6680203B2 (en) * 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
US20020115717A1 (en) * 2000-07-25 2002-08-22 Francine Gervais Amyloid targeting imaging agents and uses thereof
WO2002010750A2 (en) * 2000-07-31 2002-02-07 Maxygen, Inc. Biosensors, reagents and diagnostic applications of directed evolution
AU2001285170B2 (en) * 2000-08-21 2006-10-26 The Brigham And Women's Hospital, Inc. Methods for diagnosing a neurodegenerative condition
BRPI0113470B8 (pt) * 2000-08-24 2021-05-25 Univ Pittsburgh composto de ligação amilóide, composição farmacêutica e métodos de síntese de composto, de detecção in vivo de depósitos amilóides num indivíduo e em tecido humano ou animal, de quantificação de depósito amilóide em tecido de biópsia ou postmortem e de distinção de um cérebro de doença de alzheimer de um cérebro normal
US7270800B2 (en) * 2000-08-24 2007-09-18 University Of Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US6600947B2 (en) * 2001-03-16 2003-07-29 Nymox Corporation Method of detecting amyloid-containing lesions by autofluorescence
US20030194798A1 (en) * 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
AU2003250102B2 (en) * 2002-07-24 2009-09-17 Innogenetics N.V. Fragments of beta-amyloid as targets for vaccination against alzheimer disease
US7632816B2 (en) * 2003-03-28 2009-12-15 New York University Treatment of Alzheimer amyloid deposition
MXPA05012281A (es) * 2003-05-14 2006-05-19 Torreypines Therapeutics Inc Compuestos y uso de los mismos en la modulacion beta amiloide.
US20050048539A1 (en) * 2003-06-13 2005-03-03 The General Hospital Corporation Methods to monitor molecule conformation and molecule/molecule proximity
US20060034848A1 (en) * 2003-11-07 2006-02-16 Ayae Kinoshita Methods and compositions for treating Alzheimer's disease
US7803351B2 (en) * 2004-08-20 2010-09-28 Washington University Blood brain barrier permeation peptides
US8227621B2 (en) * 2005-06-30 2012-07-24 Li-Cor, Inc. Cyanine dyes and methods of use

Also Published As

Publication number Publication date
DE60128138D1 (de) 2007-06-06
EP1347731A2 (de) 2003-10-01
WO2002064084A3 (en) 2003-06-19
WO2002064084A2 (en) 2002-08-22
AU2002251682A1 (en) 2002-08-28
EP1347731B1 (de) 2007-04-25
DE60128138T2 (de) 2008-01-03
CA2427014A1 (en) 2002-08-22
JP2004518488A (ja) 2004-06-24
US7668586B2 (en) 2010-02-23
EP1347731A4 (de) 2004-09-08
US20030009104A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
ATE360392T1 (de) In vivo multiphoton diagnostische detektion und bilddarstellung einer neurodegenerativen erkrankung
EP1149555A3 (de) Fluoreszierendes Endoskopgerät
JP4954699B2 (ja) 蛍光内視鏡システム
JP4823906B2 (ja) 多光子顕微鏡観察、分光法、および内視鏡観察などの生物学的用途のための光ファイバー送集光システム
EP3711655B1 (de) System zur nebenschilddrüsenabtastung in echtzeit
ATE291878T1 (de) Verfahren zur vermeidung von fluoreszenzlöschung
JP6412709B2 (ja) 観察画像取得システム
WO2010083204A3 (en) Noninvasive measurement of flavonoid compounds in biological tissue
WO1995026673A3 (en) Apparatus and method for imaging diseased tissue using integrated autofluorescence
US20100268091A1 (en) Fluorescence imaging apparatus and endoscope apparatus
KR20190122890A (ko) 자가형광이 존재하는 생물학적 물질에서 타겟 형광체의 이미징
ATE429850T1 (de) Verfahren und vorrichtung zur digitalen diagnostischen multispectralabbildung
WO2007002323A3 (en) System and method for monitoring of end organ oxygenation by measurement of in vivo cellular energy status
NO20011338L (no) Kontrastmiddel som fluorescerer i et område n¶r det infraröde område og fluorescensavbildning
EP1067376A3 (de) Vorrichtung zur Messung von Fluoreszenz
WO2008143246A1 (ja) カプセル型医療装置およびカプセル型医療システム
EP1132731A3 (de) Verfahren und Vorrichtung zur Bilderzeugung mittels optischer Tomographie
WO2015164774A1 (en) Fluorescence guided surgical systems and methods gated on ambient light
EP2347703A1 (de) Verfahren und Vorrichtung zur Darstellung von krebsartigem oder vorkrebsartigem Gewebe
CA2443927A1 (en) Method for viewing tumor tissue located within a body cavity
DE50310077D1 (de) Verfahren zur verbesserung der tiefendiskriminierung optisch abbildender systeme
Jo et al. In vivo simultaneous morphological and biochemical optical imaging of oral epithelial cancer
ATE291879T1 (de) Verfahren zur vermeidung von fluoreszenzlöschung
DE50311203D1 (de) Vorrichtung zur bildgebenden Diagnose von Gewebe
ATE361699T1 (de) Analyse einer zusammenstellung mit beobachtung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1347731

Country of ref document: EP

REN Ceased due to non-payment of the annual fee